Connolly, SJ, Camm, AJ, Halperin, JL, Joyner, C, Alings, M, Amerena, J, Atar, D, Avezum, A, Blomstroem, P, Borggrefe, M, Budaj, A, Chen, S-A, Ching, CK, Commerford, P, Dans, A, Davy, J-M, Delacretaz, E, Di Pasquale, G, Diaz, R, Dorian, P, Flaker, G, Golitsyn, S, Gonzalez-Hermosillo, A, Granger, CB, Heidbuechel, H, Kautzner, J, Kim, JS, Lanas, F, Lewis, BS, Merino, JL, Morillo, C, Murin, J, Narasimhan, C, Paolasso, E, Parkhomenko, A, Peters, NS, Sim, K-H, Stiles, MK, Tanomsup, S, Toivonen, L, Tomcsanyi, J, Torp-Pedersen, C, Tse, H-F, Vardas, P, Vinereanu, D, Xavier, D, Zhu, J, Zhu, J-R, Baret-Cormel, L, Weinling, E & PALLAS Investigators 2011, '
Dronedarone in High-Risk Permanent Atrial Fibrillation',
New England Journal of Medicine, vol. 365, pp. 2268-2276.
https://doi.org/10.1056/NEJMoa1109867